Skip to content
Disclosery

EXANE DERIVATIVES: CCJ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CCJ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 247,958 CCJ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 247,958 shares
    Change vs previous 13F +12,313 shares

    2.98% of the 13F portfolio, value $5,185,549.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 235,645 shares
    Change vs previous 13F -116,746 shares

    1.93% of the 13F portfolio, value $6,854,320.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 352,391 shares
    Change vs previous 13F +276,053 shares

    1.86% of the 13F portfolio, value $7,658,620.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 76,338 shares
    Change vs previous 13F +2,164 shares

    0.41% of the 13F portfolio, value $1,658,902.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 74,174 shares
    Change vs previous 13F -70,178 shares

    0.31% of the 13F portfolio, value $1,317,278.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 144,352 shares
    Change vs previous 13F +37,438 shares

    0.72% of the 13F portfolio, value $2,397,817.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 106,914 shares
    Change vs previous 13F +2,928 shares

    0.43% of the 13F portfolio, value $1,432,723.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 103,986 shares
    Change vs previous 13F not available

    0.34% of the 13F portfolio, value $1,050,287.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).